Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026)
Envoy Medical recorded quarterly Gains from Investment Securities of $12000.0 in Q1 2026, up 114.12% quarter-over-quarter from -$85000.0 in Q4 2025, and up 35.36% year-over-year from $8865.0 in Q1 2025.
Envoy Medical's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $12000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 35.36% year-over-year to $12000.0; the TTM figure through Mar 2026 stood at -$884000.0 (down 10071.8% YoY), while the FY2025 annual figure was $348280.0, down 84.27% from the prior year.
- Gains from Investment Securities came in at $12000.0 for Q1 2026 at Envoy Medical, up from -$85000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $693000.0 in Q3 2025 to a low of -$14.4 million in Q1 2022.
- A 5-year average of -$1.1 million and a median of -$37000.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities slumped 2911.97% in 2022 and soared 328.25% in 2024, its largest moves.
- Envoy Medical's Gains from Investment Securities stood at -$30000.0 in 2022, then slumped by 576.67% to -$203000.0 in 2023, then tumbled by 281.28% to -$774000.0 in 2024, then jumped by 89.02% to -$85000.0 in 2025, then surged by 114.12% to $12000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $12000.0, -$85000.0, and $693000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Envoy Medical | 48.11 Mn | 22.86 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | -85,000.00 |
| Dec 31, 2025 | -85,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Mar 31, 2025 | 8,865.00 |
| Mar 31, 2025 | 8,865.00 |
| Dec 31, 2024 | -774,000.00 |
| Dec 31, 2024 | -774,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Sep 30, 2024 | 311,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Mar 31, 2024 | 31,955.00 |
| Mar 31, 2024 | 31,955.00 |
| Dec 31, 2023 | -203,000.00 |
| Dec 31, 2023 | -203,000.00 |
| Sep 30, 2023 | -162,667.00 |
| Sep 30, 2023 | -162,667.00 |
| Jun 30, 2023 | 266,667.00 |
| Jun 30, 2023 | 266,667.00 |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -30,000.00 |
| Dec 31, 2022 | -30,000.00 |
| Sep 30, 2022 | -1.33 Mn |
| Sep 30, 2022 | -1.33 Mn |
| Jun 30, 2022 | -3.47 Mn |
| Jun 30, 2022 | -3.47 Mn |
| Mar 31, 2022 | -14.40 Mn |
| Mar 31, 2022 | -14.40 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | -8.55 Mn |
| Sep 30, 2021 | -8.55 Mn |
| Jun 30, 2021 | -1.43 Mn |
| Jun 30, 2021 | -1.43 Mn |
| Mar 31, 2021 | 512,000.00 |
| Mar 31, 2021 | 512,000.00 |